Integra LifeSciences Holdings Corporation Resolves Violations at New Jersey Manufacturing Facility
Published: Sep 26, 2013
Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced that the United States Food and Drug Administration ("FDA") has informed the Company that it had addressed the violations in the warning letter relating to its Plainsboro, New Jersey manufacturing facility, and that the warning letter had been closed out effective September 24, 2013.
Help employers find you! Check out all the jobs and post your resume.